Abstract
Amyloid formation and aberrant protein aggregation are hallmarks of more than 30 different human diseases. The proteins that form amyloid can be divided into two structural classes: those that form compact, well-ordered, globular structures in their unaggregated state and those that are intrinsically disordered in their unaggregated states. The latter include the Aβ peptide of Alzheimer’s disease, islet amyloid polypeptide (IAPP, amylin) implicated in type 2 diabetes and α-synuclein, which is linked to Parkinson’s disease. Work in the last 10 years has highlighted the potential role of pre-amyloid intermediates in cytotoxicity and has focused attention on their properties. A number of intrinsically disordered proteins appear to form helical intermediates during amyloid formation. We discuss the spectroscopic methods employed to detect and characterize helical intermediates in homogenous solution and in membrane-catalyzed amyloid formation, with the emphasis on the application of circular dichroism (CD). IAPP is used as an example, but the methods are generally applicable.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Selkoe DJ (2004) Cell biology of protein misfolding: the examples of Alzheimer’s and Parkinson’s diseases. Nat Cell Biol 6:1054–1061
Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75:333–366
Sipe JD (1994) Amyloidosis. Crit Rev Clin Lab Sci 31:325–354
Westermark P, Andersson A, Westermark GT (2011) Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev 91:795–826
Abedini A, Raleigh DP (2009) A critical assessment of the role of helical intermediates in amyloid formation by natively unfolded proteins and polypeptides. Protein Eng Design Select 22:453–459
Taskent-Sezgin H, Marek P, Thomas R, Goldberg D, Chung J, Carrico I, Raleigh DP (2010) Modulation of p-cyanophenylalanine fluorescence by amino acid sidechains and rational design of fluorescence probes of a-helix formation. Biochemistry 49:6290–6295
Shim S-H, Gupta R, Ling YL, Strasfeld DB, Raleigh DP, Zanni MT (2009) 2DIR spectroscopy defines the pathway of amyloid formation with residue specific resolution. Proc Natl Acad Sci U S A 106:6614–6619
Lukinius A, Wilander E, Westermark GT, Engstrom U, Westermark P (1989) Co-localization of islet amyloid polypeptide and insulin in the beta-cell secretory granules of the human pancreatic-islets. Diabetologia 32:240–244
Kahn SE, Dalessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky GJ, Porte D (1990) Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes 39:634–638
Stridsberg M, Sandler S, Wilander E (1993) Cosecretion of islet amyloid polypeptide (IAPP) and insulin from isolated rat pancreatic-islets following stimulation or inhibition of beta-cell Function. Regul Pept 45:363–370
Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, Cooper GJS, Holman RR, Turner RC (1988) Islet amyloid, increased alpha-cells, reduced beta-cells and exocrine fibrosis – quantitative changes in the pancreas in type-2 diabetes. Diabetes Res 9:151–159
Lorenzo A, Razzaboni B, Weir GC, Yankner BA (1994) Pancreatic-islet cell toxicity of amylin associated with type-2 diabetes-mellitus. Nature 368:756–760
Konarkowska B, Aitken JF, Kistler J, Zhang S, Cooper GJ (2006) The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells. FEBS J 273:3614–3624
Cao P, Marek P, Noor H, Patsalo V, Tu LH, Wang H, Abedini A, Raleigh DP (2013) Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity. FEBS Lett 587:1106–1118
Hebda JA, Miranker AD (2009) The interplay of catalysis and toxicity by amyloid intermediates on lipid bilayers: insights from type II diabetes. Annu Rev Biophys 38:125–152
Cao P, Abedini A, Wang H, Tu LH, Zhang XX, Schmidt AM, Raleigh DP (2013) Islet amyloid polypeptide toxicity and membrane interactions. Proc Natl Acad Sci U S A 110:19279–19284
Dunkelberger EB, Buchanan LE, Marek P, Cao P, Raleigh DP, Zanni MT (2012) Deamidation accelerates amyloid formation and alters amylin fiber structure. J Am Chem Soc 134:12658–12667
Marek P, Pastalo V, Green D, Raleigh DP (2012) Ionic strength effects on amyloid formation by amylin are a complicated interplay among Debye screening, ion selectivity, and Hofmeister effects. Biochemistry 51:8478–8490
Stewart JCM (1980) Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 104:10–14
Williamson JA, Miranker AD (2007) Direct detection of transient alpha-helical states in islet amyloid polypeptide. Protein Sci 16:110–117
Manning MC, Woody RW (1991) Theoretical CD studies of polypeptide helices-examination of important electronic and geometric factors. Biopolymers 31:569–586
Whitmore L, Wallace BA (2008) Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases. Biopolymers 89:392–400
Scholtz JM, Baldwin RL (1992) Ann Rev Biophys Biomol Struct 21:95–118
Ling YL, Strasfeld DB, Shim SH, Raleigh DP, Zanni MT (2009) Two-dimensional infrared spectroscopy provides evidence of an intermediate in the membrane-catalyzed assembly of diabetic amyloid. J Phys Chem B 113:2498–2505
Abedini A, Singh G, Raleigh DP (2006) Recovery and purification of highly aggregation-prone disulfide-containing peptides: application to islet amyloid polypeptide. Anal Biochem 351:181–186
Nilsson MR, Raleigh DP (1999) Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin. J Mol Biol 294:1375–1385
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Zor T, Selinger Z (1996) Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies. Anal Biochem 236:302–308
Acknowledgements
This work was supported by NIH grants 1F32DK089734-02 (A.A.) and GM078114 (D.P.R.).
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Abedini, A., Cao, P., Raleigh, D.P. (2016). Detection of Helical Intermediates During Amyloid Formation by Intrinsically Disordered Polypeptides and Proteins. In: Eliezer, D. (eds) Protein Amyloid Aggregation. Methods in Molecular Biology, vol 1345. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2978-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2978-8_4
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2977-1
Online ISBN: 978-1-4939-2978-8
eBook Packages: Springer Protocols